Table 2. Adjusted association between patient characteristics and nephrology care.
Adjusted OR (95% CI) | ||
---|---|---|
Age group | ||
21-64 y | 1.00 (reference) | |
65-74 y | 0.80 (0.74-0.85) | |
≥75 y | 0.40 | 0.38-0.42 |
Male Sex | 1.29 | 1.12-1.48 |
Race | ||
White | 1.00 (reference) | |
Black | 1.81 | 1.70-1.93 |
Other | 1.10 | 1.02-1.20 |
Married (vs other) | 1.05 | 1.01-1.10 |
Urban residence (vs other) | 1.07 | 1.00-1.14 |
Copay (vs no copay) | 0.90 | 0.85-0.95 |
Zip code median annual income | ||
<$35,000 | 1.00 (reference) | |
$35,000-<$50,000 | 1.03 | 0.96-1.10 |
$50,000-<$65,000 | 1.06 | 0.99-1.14 |
≥$65,000 | 1.06 | 0.98-1.15 |
Facility complexity | ||
Low | 1.00 (reference) | |
Mid | 1.56 | 1.41-1.72 |
High | 1.47 | 1.35-1.61 |
Prior hospitalization | 1.07 | 1.02-1.13 |
Visits to non-nephrology provider | ||
0 | 1.00 (reference) | |
1-2 | 1.10 | 1.00-1.20 |
3-4 | 1.16 | 1.06-1.27 |
≥5 | 1.68 | 1.55-1.83 |
Comorbidities | ||
Diabetes | 1.14 | 1.09-1.20 |
Myocardial infarction | 0.96 | 0.87-1.05 |
Congestive heart failure | 0.90 | 0.86-0.95 |
Peripheral vascular disease | 1.14 | 1.08-1.21 |
Dementia | 0.71 | 0.65-0.79 |
Cerebrovascular disease | 1.00 | 0.94-1.06 |
Chronic liver disease | 1.00 | 0.89-1.14 |
Cancer | 0.98 | 0.92-1.03 |
Depression | 0.92 | 0.86-0.99 |
PTSD | 0.94 | 0.86-1.05 |
eGFR trajectory | ||
Improvement | 1.00 (reference) | |
Decline < 10 ml/min/ 1.73m2 per y | 0.81 | 0.77-0.85 |
Decline ≥10 ml/min/ 1.73m2 per y | 0.36 | 0.34-0.38 |
Missing or time lapse <30 d | 0.16 | 0.14-0.19 |
Abbreviations: CI, confidence interval; ESRD – end-stage renal disease, PTSD – post traumatic stress disorder, eGFR – estimated glomerular filtration rate; OR, odds ratio
adjusted for age, sex, race, marital status, place of residence, copay status, zip code median income, facility complexity, prior hospitalization, visits to non-nephrology Department of Veterans Affairs provider, diabetes, myocardial infarction, congestive heart failure, peripheral vascular disease, dementia, cerebrovascular disease, chronic liver disease, cancer, depression and PTSD, trajectory of kidney function